A

Atara Biotherapeutics
D

ATRA

12.930
USD
0.85
(7.04%)
مفتوح الان
حجم التداول
149
الربح لكل سهم
-17
العائد الربحي
-
P/E
-1
حجم السوق
74,473,568
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARRY
    -0.19500
    (-3.20%)
    5.90500 USD
    B
    BLUE
    0.19500
    (2.56%)
    7.81000 USD
    B
    BMRN
    0.040
    (0.06%)
    66.280 USD
    C
    CRSP
    -0.200
    (-0.49%)
    40.300 USD
    E
    EDIT
    -0.03000
    (-2.38%)
    1.23000 USD
    I
    INCY
    -0.080
    (-0.11%)
    69.780 USD
    L
    LGND
    -0.040
    (-0.04%)
    113.490 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار
المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).